FDA Oversight Of Lab-Developed Tests Is Likely To Lessen
On Jan. 13, 2017, the U.S. Food and Drug Administration issued a discussion paper on laboratory developed tests (LDTs).[1] The discussion paper follows FDA's late 2016 announcement[2] that, contrary to the...To view the full article, register now.
Already a subscriber? Click here to view full article